Early-Onset Alzheimer’s Coverage Act of 2026
The source supplies the latest action, but no lifecycle stage.
Latest action (5 Oct 2026): Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
H.R. 10726 is a bill introduced by Representative Sharice Davids (Democrat-Kansas). Its stated purpose is to amend Title XVIII of the Social Security Act. This amendment would create a pathway for individuals diagnosed with Alzheimer's disease to enroll in the Medicare program, a federal health insurance program primarily for people aged 65 and older, and younger people with certain disabilities. The bill's official text has not yet been published, so specific details about how this "buy-in" would function or any associated costs or eligibility requirements are not publicly available.
At this stage, H.R. 10726 has been introduced in the House of Representatives. Following its introduction, the bill would typically be referred to a relevant committee for review and consideration. The next steps in the legislative process could include hearings, committee markups, and potential votes. If passed by the House, it would then proceed to the Senate for further deliberation and voting. The bill's sponsor is a Democrat, and it was introduced in the 119th Congress.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
5 Oct 2026
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Common questions
- What does H.R. 10726 do?
- H.R. 10726 is a bill introduced by Representative Sharice Davids (Democrat-Kansas). Its stated purpose is to amend Title XVIII of the Social Security Act. This amendment would create a pathway for individuals diagnosed with Alzheimer's disease to enroll in the Medicare program, a federal health insurance program primarily for people aged 65 and older, and younger people with certain disabilities. The bill's official text has not yet been published, so specific details about how this "buy-in" would function or any associated costs or eligibility requirements are not publicly available. At this stage, H.R. 10726 has been introduced in the House of Representatives. Following its introduction, the bill would typically be referred to a relevant committee for review and consideration. The next steps in the legislative process could include hearings, committee markups, and potential votes. If passed by the House, it would then proceed to the Senate for further deliberation and voting. The bill's sponsor is a Democrat, and it was introduced in the 119th Congress.
- Has H.R. 10726 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10726. Check the latest action and official source below.
- Who sponsored H.R. 10726?
- H.R. 10726 was sponsored by Rep. Davids, Sharice [D-KS-3] (D-KS), with 0 cosponsors.
- What's the latest action on H.R. 10726?
- Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (5 Oct 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Silicosis Prevention and Treatment Act
340B Rebate Model Delay Act
More bills from Rep. Davids, Sharice [D-KS-3]
Healthy Communities Act of 2026
Maternity Care for Rural Communities Act of 2026
GAP Act
Access to Community Care Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.